Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
TEC
Bio-Techne
TECH
FX & Other Adjustments
FX & Other Adjustments at other companies
Revvity
RVTY
—
—
Bio-Rad Laboratories
BIO
—
—
Segments
By segment
See full
Protein Sciences
-$1.71M
-231%
Diagnostics And Spatial Biology
-$1.05M
-139%
Other financials
Income statement
See full
Revenue
$311.4M
-1.5%
Gross profit
$208.3M
-2.9%
Operating income
$75.5M
+95.0%
Net income
$51.0M
+126%
EPS (diluted)
$0.32
+129%
Balance sheet
See full
Cash & equivalents
$209.8M
+49.2%
Total debt
$290.3M
-31.4%
Total equity
$2.1B
+3.3%
Total assets
$2.6B
-3.5%
Cash flow
See full
Operating cash flow
$86.7M
+111%
CapEx
$9.1M
-10.2%
Free cash flow
$77.6M
+150%
Valuation
See full
Market cap
$11.22B
+43.5%
Enterprise value
$11.3B
+39.5%
P/E
74.9×
+16.9×
P/S
9.3×
+2.9×
Profitability
See full
Gross margin
65%
-0.8pp
Operating margin
14.2%
-7.9pp
Net margin
10.9%
-6.7pp
FCF margin
22.3%
+4.0pp
Returns & leverage
See full
Return on equity
6.5%
-3.9pp
Debt / equity
0.1×
-0.1×
Current ratio
4.5×
+0.8×
Watchlist
Screener
Filings
Earnings
Charts